• LDS
  • /Medical Tests
  • /Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine

Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
Medical Test

Diseases (3)
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Overview
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Clinical Utility
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Interpretation
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Reference Ranges
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Methodology
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Specimen Collection
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Additional Testing
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Turnaround Time
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

CPT
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

LOINC
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

ICD10
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Additional ICD10
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

References
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.

Panel Test Components
Access to Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine is restricted.